Article Details
Retrieved on: 2021-06-05 07:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biotechnology company reported ($0.57) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.30) by ($0.27).
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here